Cargando…

Spinocerebellar Ataxia 36: From Mutations Toward Therapies

Spinocerebellar ataxia 36 (SCA36) is a type of repeat expansion-related neurodegenerative disorder identified a decade ago. Like other SCAs, the symptoms of SCA36 include the loss of coordination like gait ataxia and eye movement problems, but motor neuron-related symptoms like muscular atrophy are...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez, Samuel, He, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931325/
https://www.ncbi.nlm.nih.gov/pubmed/35309140
http://dx.doi.org/10.3389/fgene.2022.837690
_version_ 1784671233886912512
author Lopez, Samuel
He, Fang
author_facet Lopez, Samuel
He, Fang
author_sort Lopez, Samuel
collection PubMed
description Spinocerebellar ataxia 36 (SCA36) is a type of repeat expansion-related neurodegenerative disorder identified a decade ago. Like other SCAs, the symptoms of SCA36 include the loss of coordination like gait ataxia and eye movement problems, but motor neuron-related symptoms like muscular atrophy are also present in those patients. The disease is caused by a GGCCTG hexanucleotide repeat expansion in the gene Nop56, and the demographic incidence map showed that this disease was more common among the ethnic groups of Japanese and Spanish descendants. Although the exact mechanisms are still under investigation, the present evidence supports that the expanded repeats may undergo repeat expansion-related non-AUG-initiated translation, and these dipeptide repeat products could be one of the important ways to lead to pathogenesis. Such studies may help develop potential treatments for this disease.
format Online
Article
Text
id pubmed-8931325
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89313252022-03-19 Spinocerebellar Ataxia 36: From Mutations Toward Therapies Lopez, Samuel He, Fang Front Genet Genetics Spinocerebellar ataxia 36 (SCA36) is a type of repeat expansion-related neurodegenerative disorder identified a decade ago. Like other SCAs, the symptoms of SCA36 include the loss of coordination like gait ataxia and eye movement problems, but motor neuron-related symptoms like muscular atrophy are also present in those patients. The disease is caused by a GGCCTG hexanucleotide repeat expansion in the gene Nop56, and the demographic incidence map showed that this disease was more common among the ethnic groups of Japanese and Spanish descendants. Although the exact mechanisms are still under investigation, the present evidence supports that the expanded repeats may undergo repeat expansion-related non-AUG-initiated translation, and these dipeptide repeat products could be one of the important ways to lead to pathogenesis. Such studies may help develop potential treatments for this disease. Frontiers Media S.A. 2022-03-04 /pmc/articles/PMC8931325/ /pubmed/35309140 http://dx.doi.org/10.3389/fgene.2022.837690 Text en Copyright © 2022 Lopez and He. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Lopez, Samuel
He, Fang
Spinocerebellar Ataxia 36: From Mutations Toward Therapies
title Spinocerebellar Ataxia 36: From Mutations Toward Therapies
title_full Spinocerebellar Ataxia 36: From Mutations Toward Therapies
title_fullStr Spinocerebellar Ataxia 36: From Mutations Toward Therapies
title_full_unstemmed Spinocerebellar Ataxia 36: From Mutations Toward Therapies
title_short Spinocerebellar Ataxia 36: From Mutations Toward Therapies
title_sort spinocerebellar ataxia 36: from mutations toward therapies
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931325/
https://www.ncbi.nlm.nih.gov/pubmed/35309140
http://dx.doi.org/10.3389/fgene.2022.837690
work_keys_str_mv AT lopezsamuel spinocerebellarataxia36frommutationstowardtherapies
AT hefang spinocerebellarataxia36frommutationstowardtherapies